Created at	Source	Raw Value	Validated value
July 21, 2021, 4 p.m.	usa	co-primary endpoint: Increase in anti-Spike Immunoglobulin G (IgG) titer AND positive anti-Spike neutralizing test;Dose limiting toxicity (DLT)	co-primary endpoint: Increase in anti-Spike Immunoglobulin G (IgG) titer AND positive anti-Spike neutralizing test;Dose limiting toxicity (DLT)